- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05631106
Lifestyle Interventions for Vitality and Empowerment in Seniors (LIVES)
November 18, 2022 updated by: Jeff Katula, Wake Forest University
The goal of this clinical trial is to test a newer type of high intensity interval resistance training in adults 65 years of age or older. The main aims of this study are:
- To develop study procedures in order to conduct a randomized controlled trial to test the impact of high intensity interval training on cognition in older adults. We will develop procedures for recruitment, screening, data collection, blinded randomization, HIIRT and EA interventions, safety monitoring, and data analyses.
- To determine the feasibility of using high intensity interval resistance training as an intervention. Feasibility will be shown by; 1) recruiting the target population and meeting our overall patient accrual goal of 30 participants over a 12-week period, 2) achieving an average attendance rate of ≥ 70% of the 24 scheduled sessions in the HIIRT group, 3) at least 80% retention of participants at the final follow-up assessment (week 12), and 4) successful completion of the MRI task (finishing the session with a behavioral accuracy greater than 70%) by at least 80% of participants. Acceptability will be assessed via participants' ratings on a standardized measure of treatment satisfaction and reasons for dropout. Acceptability will be indicated in 2 ways: 70% of the participants report treatment satisfaction on a standard questionnaire, and consistent collection of follow-up data across sites.
- To examine causal mechanisms and preliminary efficacy. We will examine the relationships among several proposed mediators of the expected treatment effect. We will also examine the mean change and variability of our primary outcomes.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jeffery A Katula, Ph.D
- Phone Number: (336) 758-3612
- Email: katulaj@wfu.edu
Study Contact Backup
- Name: Anthony Sali, Ph.D
- Phone Number: (336) 758-4813
- Email: saliaw@wfu.edu
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Lives within 20 miles of the school
- Does not plan to travel outside the home geographic area for an extended period during the study participation
- Willing to provide informed consent
- Willing to be randomized to either lifestyle intervention group
- Willing to complete all study procedures and assessments
- No contraindications to exercise
- Capacity to complete physical exercise
Exclusion Criteria:
- Dependent on walking device
- Claustrophobia
- Performs 30 minutes of moderate intensity exercise three times per week for the previous three months
- Joint replacement or orthopedic surgery in the previous 6-months or planning to have surgery in the next 6-months
- Uncontrolled hypertension
- Pathological neurological condition
- Parkinson's disease
- Unstable depression, anxiety, or schizophrenia (medication changes in the past 6 months)
- Experienced a concussion within the last 6 months
- Respiratory disease requiring oxygen
- Cancer requiring treatment
- Osteoarthritis
- Osteopenia or Osteoporosis
- Body mass index under 18
- Muscle wasting disease
- Hypertrophic or dilated cardiomyopathy significant cardiovascular disease (NIHA Class III/IV congestive heart failure, aortic stenosis, history of cardiac arrest, uncontrolled angina)
- Currently receiving physical therapy or cardiopulmonary rehabilitation
- Type I or insulin dependent Type II Diabetes
- Any implanted medical devices that are not compatible with fMRI scans (cardiac pacemaker or implanted cardiac defibrillator (ICD))
- Metal shavings in eyes
- Ferromagnetic piercings that cannot be taken out
- Transdermal patches that cannot be removed
- Cerebral aneurysm clip
- >14 alcoholic drinks in one week
- Not receiving medical clearance after PARQ+
- Evidence of cognitive impairment (Scoring below 32 points on the Telephone Interview of Cognitive Status)
- Site PI/Study Clinician discretion regarding medical status, appropriateness of participation or concern about intervention adherence, clinical judgement
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Stretching, Balance, Range of Motion
Participants will engage stretching, balance, and range of motion exercises 2 days per week for 12-weeks.
|
The stretching, balance, and range of motion intervention will include a rotating and varied routine of stretching exercises for large and small muscle groups, and activities to improve balance and range of motion.
Participants will attend this intervention twice a week with each session lasting 30 minutes.
|
|
Experimental: High Intensity Interval Resistance Training
Participants will perform resistance training exercises at high intensity intervals 2 days per week for 12-weeks.
|
During each group exercise session, the participants will be guided through a 5-minute warm-up, supervised to perform two sets of machine-based leg press, chest press, seated row, and shoulder press exercises at 30% of 1-RM, and guided through a cool-down.
Each exercise set will be 40 -seconds in length with instructions to perform as many repetitions as possible followed by a 20-second rest in between sets and a three-minute rest between exercises.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Executive Functioning
Time Frame: Baseline and 12-weeks
|
Executive Functioning will be operationalized as an index of several computer-based tasks assessing aspects of executive functioning: Inhibition (Stroop Test), Updating (The 4-part continuous performance task), and Switching (Shifting attention task, Symbol Digit Coding).
|
Baseline and 12-weeks
|
|
Gradual Continuous Performance Test
Time Frame: Baseline and 12-weeks
|
Participants will make continuous responses to target picture stimuli (images of cities among distractor images of mountains).
Periodically, a colored border will appear around each location, cuing the participant to attend to either the left or right picture stream.
If the currently cued stream differs from their previous focus of attention, the participant will make a saccadic eye movement.
At the same time as the color onset, a number will appear at each location.
Participants will then make an even/odd discrimination for stimuli appearing at the to-be-attended location.
|
Baseline and 12-weeks
|
|
Functional Magnetic Resonance Imagining
Time Frame: Baseline and 12-weeks
|
Participants will complete a 60-minute magnetic resonance imagining session during which will acquire a high-resolution anatomical scan, an echo planar image while participants complete the Gradual Continuous Performance Test.
This task is a cognitive task designed to measure the neural correlates of moment-by-moment fluctuations in the efficacy of sustained attention and attention shifting readiness, termed attentional flexibility, a resting state scan, and a diffusion tensor imaging to measure white matter tract integrity.
|
Baseline and 12-weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brain Derived Neurotrophic Factor
Time Frame: Baseline and 12-weeks
|
Blood will be drawn using venipuncture to collect a serum sample.
A blood analysis will be performed to examine brain derived neurotrophic factor, a marker suggesting an increase hippocampal neural growth.
|
Baseline and 12-weeks
|
|
The Physical Activity Enjoyment Scale
Time Frame: Baseline and 12-weeks
|
The physical activity enjoyment scale captures the extent to which an individual enjoys the physical activities they are currently participating in.
The individual is asked to respond to 18 items with bipolar anchors on a 7-point Likert-type scale (e.g., 1=I enjoy it, 7=I hate it; 1=I feel bored, 7=I feel interested).
|
Baseline and 12-weeks
|
|
Community Health Activities Model Program for Seniors Activity Questionnaire for Older Adults
Time Frame: Baseline and 12-weeks
|
This physical activity questionnaire tasks participants with reporting the extent to which they participated in various occupational, transport, leisure time, and home physical activities in the previous 4 weeks (e.g., "In a typical or normal week during the past 4 weeks, did you do heavy gardening?").
If the participant indicates "yes" they next indicate the weekly frequency and duration of the activity.
Following scoring, the scale produces variables capturing average weekly frequency, duration, and caloric expenditure for both total physical activity and exercise-specific activities.
|
Baseline and 12-weeks
|
|
Basic Psychological Need Satisfaction and Frustration Scales
Time Frame: Baseline and 12-weeks
|
he BPNSFS reflect the extent to which an individual experiences satisfaction and frustration in achieving the core human needs of relatedness, competence, and autonomy.
Participants respond to 24 questions (e.g., "I feel a sense of choice and freedom in the things I undertake") on a 5-point Likert-type scale where 1 indicates "Not True at All" and 5 indicates "Completely True".
The scale produces 6 subscale scores, including both frustration and satisfaction subscales for autonomy, competence, and satisfaction.
Each subscale is computed as the sum of four questionnaire items, with scores ranging from 4-20, with higher scores reflecting greater satisfaction or frustration.
|
Baseline and 12-weeks
|
|
SF-36 Health Questionnaire
Time Frame: Baseline and 12-weeks
|
The SF-36 is a generic measure of health status/health-related quality of life that consists of two norm-based composite T-scales, mental health and physical function, and 8 subscales: physical functioning, mental health, role-physical, role-emotional, bodily pain, general health, vitality, and social functioning.
|
Baseline and 12-weeks
|
|
400 Meter Walk Test
Time Frame: Baseline and 12-weeks
|
The 400 meter walk test assesses walking speed and endurance in older adults on a 20 meter course.
The timed walk covers 10 laps totaling 400 meters.
|
Baseline and 12-weeks
|
|
Short Physical Performance Battery
Time Frame: Baseline and 12-weeks
|
This measure assesses lower extremity functioning.
|
Baseline and 12-weeks
|
|
Stroop Test
Time Frame: Baseline and 12-weeks
|
This is a three part test.
Participants will be asked to respond the words "RED", "GREEN", "YELLOW", "BLUE", and "GREEN" in different colors according to the instructions provided for each part.
|
Baseline and 12-weeks
|
|
Symbol Digit Coding
Time Frame: Baseline and 12-weeks
|
The symbol digit coding test measures complex information processing accuracy, complex attention, visual-perceptual speed, and information processing speed.
|
Baseline and 12-weeks
|
|
Four-Part Continuous Performance Test
Time Frame: Baseline and 12-weeks
|
The four-part continuous performance is a test that measures the participant's working memory and sustained attention.
|
Baseline and 12-weeks
|
|
Shifting Attention Test
Time Frame: Baseline and 12-weeks
|
The shifting attention test is a measure of ability to shift from one instruction set to another quickly and accurately.
Participants will be instructed to match geometric objects either by shape or by color.
|
Baseline and 12-weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
November 1, 2022
Primary Completion (Anticipated)
August 1, 2023
Study Completion (Anticipated)
December 1, 2023
Study Registration Dates
First Submitted
November 18, 2022
First Submitted That Met QC Criteria
November 18, 2022
First Posted (Actual)
November 30, 2022
Study Record Updates
Last Update Posted (Actual)
November 30, 2022
Last Update Submitted That Met QC Criteria
November 18, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- IRB00024800
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.